Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGAV | P06756 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | RXRG | P48443 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17207304 | 0.84 | TAS2R14 (0.39) | ADRA2BADRA2CTAS2R14CES2PTPN1 | |
| SCHEMBL24780639 | 0.80 | ADRA2B (0.37) | ADRA2BADRA2CTAS2R14PTPN1IDO1 | |
| SCHEMBL20610195 | 0.78 | ADRA2B (0.51) | ADRA2BADRA2CTAS2R14CES2PTPN1 | |
| SCHEMBL6227551 | 0.78 | CES2 (0.44) | CES2IDO1ADRB1MAPTRAPGEF4 | |
| SCHEMBL29890941 | 0.77 | PTPN1 (0.61) | ADRA2BADRA2CTAS2R14CES2PTPN1 | |
| SCHEMBL933875 | 0.77 | PTPN1 (0.61) | ADRA2BADRA2CTAS2R14CES2PTPN1 | |
| SCHEMBL440959 | 0.76 | CES2 (0.58) | CES2IDO1ADRB1MAPTRAPGEF4 | |
| SCHEMBL20905128 | 0.75 | IDO1 (0.44) | ADRA2BADRA2CTAS2R14PTPN1IDO1 | |
| SCHEMBL20905127 | 0.75 | IDO1 (0.44) | ADRA2BADRA2CTAS2R14PTPN1IDO1 | |
| SCHEMBL11235815 | 0.75 | ADRA2B (0.35) | ADRA2BADRA2CTAS2R14PTPN1RAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4157898-B1 | CHEMICALLY CONVERTED CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-04-29 | — | — | EP | claimed |
| CN-119395917-A | Preparation method of anti-mode polymer stabilized cholesteric liquid crystal intelligent window with low energy consumption and high privacy | 哈尔滨工业大学 | 2025-02-07 | — | — | CN | claimed |
| CN-115667328-B | Catalyst for chemical conversion | 陶氏环球技术有限责任公司 | 2024-11-08 | — | — | CN | claimed |
| CN-117646229-A | Method for preparing ammonia by catalyzing NO through ultra-small copper nanoclusters | 广州惠清环保技术有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117624520-A | Trifluoromethyl modified pyrenyl covalent organic framework material, and preparation method and application thereof | 中国石油大学(华东) | 2024-03-01 | — | — | CN | claimed |
| CN-116747905-A | Preparation of ultra-small palladium nanocluster and application thereof in eliminating nitrate nitrogen in wastewater | 广州惠清环保技术有限公司 | 2023-09-15 | — | — | CN | claimed |
| US-20230203218-A1 | CHEMICALLY CONVERTED CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-29 | — | — | US | claimed |
| CN-115322644-B | Modified alkynyl polymer coating constructed in situ at interface and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-06-02 | — | — | CN | claimed |
| EP-4157898-A1 | CHEMICALLY CONVERTED CATALYSTS | Dow Global Technologies LLC (US) | 2023-04-05 | — | — | EP | claimed |
| CN-115667328-A | Catalyst for chemical conversion | 陶氏环球技术有限责任公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115322644-A | Modified alkynyl polymer coating constructed in situ at interface and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-11-11 | — | — | CN | claimed |
| CN-114874088-A | Acetylenic acid and preparation method thereof | 中国科学院上海高等研究院 | 2022-08-09 | — | — | CN | claimed |
| WO-2021243158-A1 | CHEMICALLY CONVERTED CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-12-02 | — | — | WO | claimed |
| EP-3623394-A1 | METALLACYCLOALKYLENE COMPLEXES AND USE FOR ALKYNE POLYMERIZATION TO CYCLIC POLYACETYLENES | University of Florida Research Foundation, Inc. (US) | 2020-03-18 | — | — | EP | claimed |
| EP-1337512-B1 | (4-ACYLAMINOPIPERIDIN-1-YL) ACETAMIDES AS NEUROKININ ANTAGONISTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2007-06-13 | — | — | EP | claimed |
| EP-4157898-B1 | CHEMICALLY CONVERTED CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12550608-B2 | Organic light emitting diode and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2026-02-10 | — | — | US | disclosed |
| EP-1149067-A1 | 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-6310247-B1 | HAS APOPTOTIC ACTIVITY USEFUL FOR PROPHYLAXIS AND THERAPY OF CANCER | HOFFMANN-LA ROCHE INC. | 2001-10-30 | — | — | US | disclosed |
| WO-2000035856-A1 | 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12550608-B2 | Organic light emitting diode and organic light emitting device including the same | HCN1, HCN4, HCN2 | ADRA2B 2282/4885ADRA2C 2227/4885TAS2R14 3681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.